|
A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
RECRUITINGPhase 2Sponsored by Alkermes, Inc.
Actively Recruiting
PhasePhase 2
SponsorAlkermes, Inc.
Started2026-10
Est. completion2028-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07901179
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of ALKS 7290 following oral administration in adult participants with Major Depressive Disorder.
Eligibility
Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria: * Meets the DSM-5 criteria for MDD, as confirmed by both MINI and an adequate clinical psychiatric evaluation. * Is otherwise healthy as determined by medical evaluation, including medical history, physical examination, laboratory tests, and cardiac monitoring. * Participants must be stable on permitted medication prior to screening. * An inadequate response to an adequate dosage of antidepressant therapy in the current depressive episode. * Symptoms of depression that are considered moderate to severe, based on assessments completed with the study team during both screening and baseline visits. * Has a BMI within 18 to 35 kg/m2 at Screening Exclusion Criteria: * Diagnosis of schizophrenia, schizoaffective disorder, or bipolar I or II disorder, moderate to severe substance use disorder * Significant problems with memory, thinking, learning or understanding that could make it difficult to complete study activities or follow study instructions. This includes conditions such as dementia or other disorders affecting thinking and memory that have been present within the past two years. * Participant poses a current suicide risk as assessed by the Investigator or as confirmed by the C-SSRS * Any other psychiatric condition that could interfere with participation in the study.
Conditions2
DepressionMajor Depressive Disorder (MDD)
Interventions1
Locations1 site
Alkermes Investigator Site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorAlkermes, Inc.
Started2026-10
Est. completion2028-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07901179